Research advances in epidemiological situation and diagnosis and treatment of metabolism-associated fatty liver disease / 解放军医学杂志

ABSTRACT

Metabolism-associated fatty liver disease(MAFLD),formerly known as non-alcoholic fatty liver disease(NAFLD),is one of the most popular chronic liver diseases in the world,and has become one of the main causes of liver cirrhosis,end-stage liver disease,and primary liver cancer.In recent years,the prevalence of MAFLD has gradually increased in China,the Asia Pacific region,and even globally,increasing the medical and socio-economic burden.The exploration of the epidemiology and risk factors of this disease at home and abroad has also gradually increased.Meanwhile,due to the scarcity of MAFLD treatment drugs,their drug treatment has become a hot issue that needs to be urgently addressed in clinical practice.In recent years,there has been an increase in the number of drugs entering the clinical trial stage.Based on this,the current epidemiological status,risk factors,diagnostic criteria,and treatment research progress of MAFLD have been reviewed in order to provide new ideas and directions for the clinical diagnosis,treatment,and scientific research of MAFLD.